Annual report [Section 13 and 15(d), not S-K Item 405]

Equity Incentive Plan (Details Narrative)

v3.26.1
Equity Incentive Plan (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Jan. 01, 2025
Jan. 01, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Common stock, shares authorized 250,000,000 250,000,000    
Stock based compensation expense $ 143,732 $ 657,649    
2021 Omnibus Equity Incentive Plan [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Common stock, shares authorized     12,588 4,061
Number of shares authorized for issuance 20,581      
Common stock reserved for issuance 13      
Stock awards granted, exercisable period 10 years      
Stock awards granted, vesting period four years      
Description of stock option cancellation in accordance with an option cancellation agreement. Accordingly, 674 of the 676 stock options outstanding as of December 31, 2023, were cancelled in February 2024.      
Stock based compensation expense $ 568,372      
Stock options, vested fair value $ 145,587 $ 60,263    
Share issued price per share $ 2.32      
Unrecognized stock based compensation expense $ 200,000      
Weighted average exercise period 2 years 7 months 6 days